Sign up to access historical data
Similar companies
| Company | Est. Transaction Value | |
|---|---|---|
 |
WalgreensWBA |
-$59,000 |
 |
TargetTGT |
-$69,000 |
 |
Home DepotHD |
$99,000 |
 |
Lowe'sLOW |
-$64,000 |
 |
CostcoCOST |
-$150,000 |
Trades by US Politicians
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Dwight Evans | Nov 21, 2025 | Sell | $1K - $15K |
| Val Hoyle | Sep 23, 2025 | Sell | $1K - $15K |
| Adam Smith | Aug 8, 2025 | Sell | $1K - $15K |
| Rob Bresnahan | May 15, 2025 | Sell | $1K - $15K |
| Michael McCaul | Apr 10, 2025 | Sell | $100K - $250K |
| Julie Johnson | Apr 1, 2025 | Sell | $1K - $15K |
| Rob Bresnahan | Feb 25, 2025 | Buy | $1K - $15K |
| James French Hill | Jan 31, 2025 | Sell | $15K - $50K |
| Gil Cisneros | Jan 24, 2025 | Buy | $1K - $15K |
| Julie Johnson | Jan 15, 2025 | Sell | $1K - $15K |
| Michael McCaul | Jan 13, 2025 | Buy | $100K - $250K |
| Julia Letlow | Dec 11, 2024 | Sell | $1K - $15K |
| Valerie Hoyle | Oct 29, 2024 | Buy | $1K - $15K |
| Julia Letlow | Oct 25, 2024 | Buy | $1K - $15K |
| Thomas Suozzi | Oct 24, 2024 | Sell | $1K - $15K |
| Ro Khanna | Sep 9, 2024 | Sell | $1K - $15K |
| Earl Blumenauer | Jun 27, 2024 | Sell | $1K - $15K |
| Michael McCaul | Jun 5, 2024 | Buy | $1K - $15K |
| Rohit Khanna Democrat | May 29, 2024 | Sell | $1K - $15K |
| Rohit Khanna Democrat | May 28, 2024 | Sell | $15K - $50K |
| William Keating Democrat | May 17, 2024 | Sell | $1K - $15K |
| Ro Khanna | May 7, 2024 | Buy | $1K - $15K |
| Rohit Khanna Democrat | Apr 26, 2024 | Buy | $1K - $15K |
| Rohit Khanna Democrat | Feb 2, 2024 | Sell | $1K - $15K |
FAQ - Congress Trading
Dwight Evans sold CVS Health shares most recently on November 21, 2025.
Michael McCaul has bought the most CVS stock in the last 2 years, with an estimated value of $180,000.
Michael McCaul has sold the most CVS stock in the last 2 years, with an estimated value of $180,000.
The net value of trades by US politicians for CVS Health in the last 2 years is negative, amounting to -$110,000. This suggests that US politicians do not believe in the success of the company for various reasons.
Over the last 2 years, insider transactions for CVS Health have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering politicians might have insights or reasons not immediately apparent to the public.
Monitoring US politicians' stock trades is valuable because they may have inside information about upcoming policies that could affect stock values, providing investors with valuable clues for making informed decisions.
